ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

High Efficacy of Ledipasvir/Sofosbuvir with Ribavirin in HCV Genotype-1 Infected Patients with Decompensated Liver Disease: Analysis by MELD Score from the SOLAR-1 and SOLAR-2 Trials.

M. Charlton,1 E. Yoshida,2 M. Bouliere,3 S. Flamm,4 A. Muir,5 M. Fried,6 N. Terrault,7 S. Arterburn,8 C. Yun,8 P. Pang,8 A. Osinusi,8 J. Spellman,8 M. Natha,8 D. Brainard,8 J. McHutchison,8 M. Manns,9 N. Afdhal.10

1Intermountain Medical Center, Salt Lake City
2Vancouver General Hospital, Vancouver, Canada
3Hopital Saint Joseph, Marseilles, France
4Northwestern University, Chicago
5Duke University, Durham
6University of North Carolina, Chapel Hill
7UCSF, SF
8Gilead Sciences Inc, Foster City
9Hannover Medical School, Hannover, Germany
10BIDMC, Boston.

Meeting: 2016 American Transplant Congress

Abstract number: 265

Keywords: Hepatitis C, Liver cirrhosis, Liver failure, Liver transplantation

Session Information

Date: Monday, June 13, 2016

Session Name: Concurrent Session: Viral Hepatitis

Session Time: 2:30pm-4:00pm

 Presentation Time: 3:06pm-3:18pm

Location: Ballroom A

Related Abstracts
  • Safety and Efficacy of Ledipasvir/Sofosbuvir (LS) with or without Ribavirin (RBV) for Treatment of Recurrent Hepatitis C Infection Post-Liver Transplant.
  • Living Donor Liver Transplantation for High MELD Score Patients

Introduction: HCV infected patients with decompensated liver disease have significant morbidity & mortality. The efficacy & safety of LDV/SOF + RBV was evaluated in a pooled analysis of HCV GT-1 infected patients with decompensated liver disease enrolled in the SOLAR-1 & SOLAR-2 clinical trials.

Methods: Patients with HCV GT-1 infection & decompensated liver disease (CPT-B or CPT-C) who were either pretransplant or post liver transplant were included in the safety analysis. Patients were randomized 1:1 to receive 12 or 24 weeks of LDV/SOF+RBV treatment. These analyses were performed according to MELD categories of MELD ≤10, 11-14, 15-18 and >/= 19).

Results: 309 patients were included for safety analysis (202 pretransplant & 107 posttransplant). The majority of patients were treatment experienced (74 %), white (93%), males (73%), with IL28B non-CC (79%). The combined 12 & 24 week SVR12 rates by baseline MELD categories were ≤10 (100% & 97%), 11-14 (87% & 92%), 15-18 (83% & 68%) and ≥19 (70% & 83%) for pretransplant & posttransplant patients respectively. There were few relapses, 13 (7.3%) & 4 (4%) in the pretransplant & posttransplant groups respectively. The incidence of SAEs by MELD categories that were ≤10 were (18% & 24%), 11-14 (23% & 27%), 15-18 (37% & 42%) and ≥19 (58% & 67%) for pretransplant and posttransplant patients respectively. There were 14 (4.5%) treatment-emergent deaths with a higher incidence in patients with MELD scores ≥ 15 (7.3% vs 3.3%). Deaths were primarily associated with clinical progression of end stage liver disease; all were considered unrelated to study drug.

Conclusions: In HCV GT-1 infected patients with decompensated liver disease, LDV/SOF+RBV for 12 or 24 weeks resulted in high SVR rates. Patients with higher MELD scores ≥ 15 had higher rates of SAEs and death due to the severity of their underlying liver disease.

CITATION INFORMATION: Charlton M, Yoshida E, Bouliere M, Flamm S, Muir A, Fried M, Terrault N, Arterburn S, Yun C, Pang P, Osinusi A, Spellman J, Natha M, Brainard D, McHutchison J, Manns M, Afdhal N. High Efficacy of Ledipasvir/Sofosbuvir with Ribavirin in HCV Genotype-1 Infected Patients with Decompensated Liver Disease: Analysis by MELD Score from the SOLAR-1 and SOLAR-2 Trials. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Charlton M, Yoshida E, Bouliere M, Flamm S, Muir A, Fried M, Terrault N, Arterburn S, Yun C, Pang P, Osinusi A, Spellman J, Natha M, Brainard D, McHutchison J, Manns M, Afdhal N. High Efficacy of Ledipasvir/Sofosbuvir with Ribavirin in HCV Genotype-1 Infected Patients with Decompensated Liver Disease: Analysis by MELD Score from the SOLAR-1 and SOLAR-2 Trials. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/high-efficacy-of-ledipasvirsofosbuvir-with-ribavirin-in-hcv-genotype-1-infected-patients-with-decompensated-liver-disease-analysis-by-meld-score-from-the-solar-1-and-solar-2-trials/. Accessed April 20, 2021.

« Back to 2016 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Penis Transplantation: First U.S. Experience.
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.